These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 1390213)

  • 21. Three cases of platelet alloimmunisation associated with the presence of a novel platelet-specific antibody.
    Masters R; Taaning E
    Vox Sang; 1998; 75(3):242-6. PubMed ID: 9852414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Frequency and causes of refractoriness in multiply transfused patients.
    Legler TJ; Fischer I; Dittmann J; Simson G; Lynen R; Humpe A; Riggert J; Schleyer E; Kern W; Hiddemann W; Köhler M
    Ann Hematol; 1997 Apr; 74(4):185-9. PubMed ID: 9174547
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Platelet alloimmunization after long-term red cell transfusion in transfusion-dependent thalassemia patients.
    Lo SC; Chang JS; Lin SW; Lin DT
    Transfusion; 2005 May; 45(5):761-5. PubMed ID: 15847666
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of platelet alloantibodies by flow cytometry. Characterization and clinical significance.
    Rosenfeld CS; Bodensteiner DC
    Am J Clin Pathol; 1986 Feb; 85(2):207-12. PubMed ID: 3946304
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A cross-matching procedure for the selection of platelet donors for alloimmunized patients.
    Waters AH; Minchinton RM; Bell R; Ford JM; Lister TA
    Br J Haematol; 1981 May; 48(1):59-68. PubMed ID: 7018556
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low incidence of specific anti-platelet antibodies detected by the MAIPA assay in the serum of thrombocytopenic MDS patients and lack of correlation between platelet autoantibodies, platelet lifespan and response to danazol therapy.
    Hebbar M; Kaplan C; Caulier MT; Wattel E; Morel P; Wetterwald M; Bauters F; Fenaux P
    Br J Haematol; 1996 Jul; 94(1):112-5. PubMed ID: 8757517
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Occurrence of allogeneic HLA and non-HLA antibodies after transfusion of prestorage filtered platelets and red blood cells: a prospective study.
    Novotny VM; van Doorn R; Witvliet MD; Claas FH; Brand A
    Blood; 1995 Apr; 85(7):1736-41. PubMed ID: 7703481
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Platelet antibody screening in patients with leukemia and aplastic anemia.
    Chow MP; Yung CH; Tzeng JL; Hu HY; Lin WM
    Zhonghua Yi Xue Za Zhi (Taipei); 1991 Apr; 47(4):237-41. PubMed ID: 1646672
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In utero exposure to alloantigens primes alloimmunization to platelet transfusion in mice.
    Poston JN; Jash A; Hannan LM; Hay AM; Usaneerungrueng C; Howie HL; Kapp LM; Zimring JC
    Transfusion; 2021 Mar; 61(3):687-691. PubMed ID: 33336414
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Frequency and characterization of platelet-specific antibodies in patients who received multiple platelet transfusions.
    Lo SC; Lin DT; Lin SW; Chang JS
    J Formos Med Assoc; 2000 Dec; 99(12):902-5. PubMed ID: 11155742
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human platelet antigen (HPA)-specific immunoglobulin M antibodies in neonatal alloimmune thrombocytopenia can inhibit the binding of HPA-specific immunoglobulin G antibodies.
    Hopkins M; Lucas G; Calvert A; Bendukidze N; Green F; Kotecha K; Poles A
    Transfusion; 2017 May; 57(5):1267-1271. PubMed ID: 28236317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HLA antigen and antibody association in platelet-alloimmunized patients.
    Chow MP; Lin JS; Lin CK; Kuo BI; Yung CH; Lyou JY; Hu HY; Tzeng JL; Lee TD
    Zhonghua Yi Xue Za Zhi (Taipei); 1993 May; 51(5):329-32. PubMed ID: 8334558
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of alloimmunization in platelet survival studies.
    Mueller-Eckhardt G; Breidenbach M; Mahn I; Mueller-Eckhardt C
    Blut; 1980 Aug; 41(2):93-9. PubMed ID: 7437528
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platelet crossmatching with lymphocytotoxicity test: an effective method in alloimmunized Chinese patients.
    Chow MP; Yung CH; Hu HY; Tzeng JL; Lin WM; Lin CK
    Transfusion; 1991 Sep; 31(7):595-9. PubMed ID: 1891789
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serological studies in patients on platelet- and granulocyte-substitution therapy.
    Pegels JG; Bruynes EC; Engelriet CP; von dem Borne AE
    Br J Haematol; 1982 Sep; 52(1):59-68. PubMed ID: 7115629
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modification of solid phase red cell adherence assay for the detection of platelet antibodies in patients with thrombocytopenia.
    Vongchan P; Nawarawong W; Linhardt RJ
    Am J Clin Pathol; 2008 Sep; 130(3):455-66. PubMed ID: 18701420
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet transfusion refractoriness and anti-HLA immunization.
    Blandin L; Dougé A; Fayard A; Bay JO; Berlie G; Pereira B; Lemal R; Rouzaire P
    Transfusion; 2021 Jun; 61(6):1700-1704. PubMed ID: 33709433
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Evaluation of the microplate enzyme-linked assay with isolation of glycoprotein IIb/IIIa from platelet membranes: comparison with immunofluorescent tests and monoclonal antibodies].
    Maślanka K; Brojer E; Gromadzka G; Zupańska B
    Acta Haematol Pol; 1993; 24(4):373-9. PubMed ID: 8303984
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elution of granulocyte and platelet antibodies.
    Helmerhorst FM; van Oss CJ; Bruynes EC; Engelfriet CP; von dem Borne AE
    Vox Sang; 1982; 43(4):196-204. PubMed ID: 6182693
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of platelet refractoriness in oncohematologic patients.
    Ferreira AA; Zulli R; Soares S; Castro Vd; Moraes-Souza H
    Clinics (Sao Paulo); 2011; 66(1):35-40. PubMed ID: 21437433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.